PROSTAGLANDINS AND CONGENERS .29. (16RS)-(+/-)-15-DEOXY-16-HYDROXY-16-VINYL-PROSTAGLANDIN E2, AN ORALLY AND TRANSDERMALLY ACTIVE HYPOTENSIVE AGENT OF PROLONGED DURATION

被引:19
作者
BIRNBAUM, JE
CERVONI, P
CHAN, PS
CHEN, SML
FLOYD, MB
GRUDZINSKAS, CV
WEISS, MJ
DESSY, F
机构
[1] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965
[2] UNIV CLIN BRUSSELS,DIV PHARMACEUT,B-1060 BRUSSELS,BELGIUM
关键词
D O I
10.1021/jm00347a003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:492 / 494
页数:3
相关论文
共 22 条
[11]  
FERRARA JD, COMMUNICATION
[12]  
FLOYD MB, 1975, PROSTAGLANDINS, V10, P289
[14]  
GRUDZINSKAS CV, 1980, ACS S SER, V118, P362
[15]   STRUCTURE ACTIVITY STUDIES LEADING TO A TISSUE-SELECTIVE HYPOTENSIVE PROSTAGLANDIN ANALOG, 13,14-DIHYDRO-16-PHENYL-OMEGA-TETRANOR PGE2 [J].
JOHNSON, MR ;
SCHAAF, TK ;
CONSTANTINE, JW ;
HESS, HJ .
PROSTAGLANDINS, 1980, 20 (03) :515-520
[16]  
Kurzrok R, 1930, P SOC EXP BIOL MED, V28, P268
[17]   PROSTAGLANDINS, KININS AND THE REGULATION OF BLOOD-PRESSURE [J].
MCGIFF, JC ;
QUILLEY, J .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1980, 2 (3-4) :729-740
[18]  
PAPPO R, 1979, CHEM BIOCH PHARM ACT, P17
[19]  
SHIMADA Y, 1975, Osaka City Medical Journal, V21, P71
[20]  
WEBER PC, 1981, INT J OBESITY, V5, P125